Applied Therapeutics, Inc.
Applied Therapeutics, Inc. (APLT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · APLT · as of Sep 30, 2025
Ownership Breakdown
78
Institutional Holders
▼ 2 vs Q2
$57.20M
Total Inst. Value
▲ $29.83M vs Q2
144.30M
Shares Outstanding
freeFloat 83.04%
94.76M
13F Shares Held
▲ 6.70M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
APLT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. pharmaceutical preparations | 21.40M | 14.70% | 14.70% | $12.84B | Nov 14, 2025 | ▲ 2.72M |
VESTAL POINT CAPITAL, LP pharmaceutical preparations | 14.25M | 9.79% | 9.79% | $8.62B | Nov 14, 2025 | ▲ 2.75M |
PROPEL BIO MANAGEMENT, LLC pharmaceutical preparations | 11.29M | 7.75% | 7.75% | $6.83B | Nov 12, 2025 | — held |
KNOLL CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 7.80M | 5.36% | 5.36% | $4.71B | Nov 14, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 5.10M | 3.51% | 3.51% | $3.09B | Nov 7, 2025 | ▲ 368.7K |
SIMPLIFY ASSET MANAGEMENT INC. pharmaceutical preparations | 4.49M | 3.08% | 3.08% | $2.71B | Oct 20, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 3.84M | 2.64% | 2.64% | $2.33B | Nov 12, 2025 | ▼ 1.38M |
PNC FINANCIAL SERVICES GROUP, INC. pharmaceutical preparations | 2.90M | 1.99% | 1.99% | $1.76B | Nov 7, 2025 | NEW |
PATHSTONE HOLDINGS, LLC pharmaceutical preparations | 2.64M | 1.82% | 1.82% | $1.60B | Nov 13, 2025 | — held |
MARSHALL WACE, LLP pharmaceutical preparations | 2.54M | 1.75% | 1.75% | $1.53B | Nov 13, 2025 | ▲ 998.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
16
Increased
+10.33M shares7
New Positions
first time holders15
Decreased
−3.48M shares0
Sold Out
fully exitedNet shares change (top 50)
+6.86M
+10.33M / −3.48M
Net new holders
+8
7 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
APLT insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
25
Sell transactions
0.04
Buy/Sell ratio
$7M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Kanter Stacy J. director | Feb 3, 2026 | D-Return | 22,500 | $0.09 | $2.0K | 42.5K | Form 4 ↗ |
Kanter Stacy J. director | Feb 3, 2026 | D-Return | 200,000 | $0.40 | $79.0K | 0 | Form 4 ↗ |
Kanter Stacy J. director | Feb 3, 2026 | U-Tender | 42,500 | $0.09 | $3.7K | 0 | Form 4 ↗ |
Kanter Stacy J. director | Feb 3, 2026 | D-Return | 16,500 | $1.05 | $17.3K | 0 | Form 4 ↗ |
Hooks Corwin Dale Chief Commercial Officer | Dec 19, 2025 | Award | 312,500 | — | — | 868.3K | Form 4 ↗ |
Hooks Corwin Dale Chief Commercial Officer | Feb 3, 2026 | D-Return | 862,500 | $0.09 | $75.9K | 5.8K | Form 4 ↗ |
Hooks Corwin Dale Chief Commercial Officer | Feb 3, 2026 | U-Tender | 5,753 | — | — | 0 | Form 4 ↗ |
Chinoporos Constantine See Remarks | Dec 19, 2025 | Award | 437,500 | — | — | 1.06M | Form 4 ↗ |
Chinoporos Constantine See Remarks | Feb 3, 2026 | D-Return | 1,000,000 | $0.09 | $88.0K | 57.1K | Form 4 ↗ |
Chinoporos Constantine See Remarks | Feb 3, 2026 | U-Tender | 57,111 | — | — | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Applied Therapeutics, Inc. (APLT) is primarily owned by institutional investors, who hold approximately 65.7% of total shares outstanding. Company insiders own approximately 16.96%, while retail and public investors account for the remaining 17.37%.
The largest institutional shareholder of Applied Therapeutics, Inc. is T. ROWE PRICE INVESTMENT MANAGEMENT, INC., holding approximately 21.40 million shares — equal to 14.70% of outstanding shares — as of September 30, 2025.
A total of 78 institutional investors currently hold APLT stock, with a combined institutional value of approximately $57,199,409 as of the most recent 13F filing period.
Frequently asked questions
APLT ownershipApplied Therapeutics, Inc. (APLT) is primarily owned by institutional investors, who hold approximately 65.7% of shares. The largest shareholder is T. ROWE PRICE INVESTMENT MANAGEMENT, INC. with a 14.70% stake. Company insiders hold 16.96%. Data sourced from SEC Form 13F as of September 30, 2025.